We are live on ! Find out more
TOVX icon

Theriva Biologics

32 hedge funds and large institutions have $3.17M invested in Theriva Biologics in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 7

1.99% less ownership

Funds ownership: 9.01% → 7.02% (-2%)

3% less funds holding

Funds holding: 33 → 32 (-1)

11% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 9

41% less capital inflows, than outflows

Capital inflows: $304K | Capital outflows: $516K

Holders
32
Holders Change
-1
Holders Change %
-3.03%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
8
Reduced
7
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TOVX Hedge Fund Activity: Q1 2022 in Review

32 of the 6,366 institutional investors tracked by Wall St. Rank reported a position in Theriva Biologics (TOVX) for Q1 2022, worth a combined $3.17M — down 2.2% from $3.24M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of TOVX and 8 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 8 added.

The largest buyer was Jane Street, opening a new position worth an estimated $76.8K. The largest seller was Truist Financial, exiting entirely with an estimated $299K sold.

  • 32 institutional investors held Theriva Biologics (TOVX) as of Q1 2022, down from 33 in Q4 2021.
  • Funds reported $3.17M of Theriva Biologics stock for Q1 2022, down 2.2% quarter-over-quarter.
  • 8 funds opened new Theriva Biologics positions in Q1 2022 and 9 closed out, a net change of -1 holder.
  • The largest Theriva Biologics buyer in Q1 2022 was Jane Street, an estimated $76.8K added.
  • The largest Theriva Biologics seller in Q1 2022 was Truist Financial, an estimated $299K sold.

Based on aggregated 13F filings for Q1 2022.